In an exclusive interview with Le Figaro, Reda Guiha, the President of Pfizer in France, discusses the profound pride he feels for his colleagues who have significantly contributed to global health, particularly during the COVID-19 pandemic. He highlights that their efforts have saved millions of lives, emphasizing the unique pride that comes with such impactful work.

Guiha also shares insights about Pfizer's presence in France, noting that the company has been actively engaged in the country since 1972. The company moved its headquarters to a strategically located building in the Porte d'Orléans area of Paris, selected due to its promising outlook for future growth. He describes the high-security environment of their office which reflects the company's commitment to innovation and safety in the biopharmaceutical field.

The conversation reveals Guiha's strong connection to his team and their mission, underscoring the vital role of biopharmaceutical companies in societal health and the pride derived from contributing to life-saving advancements. His statements resonate beyond the corporate narrative and touch on the broader implications of public health contributions, particularly in challenging times like the recent pandemic.